Prader-Willi Syndrome and Early-onset Morbid Obesity Natural History
The purposes of this study are to a) evaluate effects of growth hormone
treatment in people with Prader-Willi Syndrome (PWS) when started at different
ages, b) compare people with PWS to people with early-onset morbid obesity (EMO),
and c) collect information to use as a foundation for future research studies.
Information gained from this study may help tailor long term management for
individuals with PWS and EMO. This research study is being conducted under the
auspices of the Rare Disease Clinical Research Network (RDCRN) at currently 4
institutions across the USA. It is funded by the NIH.
To learn more about the study and eligibility, go to
More information about this study [click here]
Please note that some individuals may not qualify for the study and some
sites may have already recruited enough subjects at the present time.